Richard Drake trained in Manchester and the Northwest of England. He became a member of the Royal College of Psychiatrists in 1996 and won the Laughlin prize and Gaskell Medal. He started his research career working on the SOCRATES trial of cognitive-behavioural therapy in early psychosis. He became a Senior Lecturer in 2002 and a Professor in 2021.
As an Honorary Consultant Psychiatrist at Manchester Mental Health & Social Care NHS Trust and then Greater Manchester Mental Health NHS Foundation Trust (https://www.gmmh.nhs.uk/) he was involved in developing rehabilitation services across Manchester. Since 2019 he has been a consultant in North Manchester Early Intervention Service, working full time there March-December 2020.
He is also a clinical co-lead for Mental Health in Health Innovation Manchester, Chair of the Manchester Medication Management Committee and part of the schizophrenia guidelines committee and teaching faculty of the British Association of Psychopharmacology. His aim is to improve translation of research evidence and novel treatments into clinical practice.
He advised the charity Rethink Mental Illness on setting up the Innovation Network and have spoken to local groups. He has lectured on schizophrenia and the effect of antipsychotic drugs at various events for mixed audiences including professionals, patients, and carers. He has worked with various advisory groups of service users and carers on developing informative materials and collaborative prescribing methods. he has also collaborated with Dr Dawn Edge & Prof Kathryn Abel on developing methods of informing patients and carers.
Memberships of committees and professional bodies
British Association of Psychopharmacology (teaching faculty, Schizophrenia treatment guidelines committee)
International Early Psychosis Association
Royal College of Psychiatrists
Manchester Medical Society (was Psychiatry section council member, nominated to be President of section)